CENI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.438
EU - Europa 2.292
AS - Asia 525
AF - Africa 5
SA - Sud America 2
Totale 6.262
Nazione #
US - Stati Uniti d'America 3.431
PL - Polonia 812
IE - Irlanda 346
SE - Svezia 329
IT - Italia 301
HK - Hong Kong 179
CN - Cina 124
RU - Federazione Russa 120
DE - Germania 94
UA - Ucraina 94
SG - Singapore 84
JO - Giordania 71
FI - Finlandia 61
GB - Regno Unito 56
CH - Svizzera 41
IN - India 29
BE - Belgio 18
VN - Vietnam 16
TR - Turchia 10
FR - Francia 9
ES - Italia 8
KR - Corea 6
CA - Canada 5
SC - Seychelles 4
TW - Taiwan 4
NL - Olanda 3
BR - Brasile 2
HN - Honduras 2
JP - Giappone 2
EG - Egitto 1
Totale 6.262
Città #
Warsaw 812
Fairfield 477
Dublin 346
Chandler 343
Ashburn 262
Woodbridge 262
Cambridge 216
Seattle 203
Houston 187
Wilmington 178
Jacksonville 164
Ann Arbor 143
Lawrence 112
Hong Kong 110
Altamura 106
Princeton 82
Boardman 74
Boston 64
Buffalo 59
Beijing 57
Florence 56
Singapore 48
Shanghai 40
Bern 39
San Diego 30
Medford 29
Pune 27
New York 26
Falls Church 23
Kent 21
Bremen 20
Brussels 18
Dong Ket 16
Norwalk 16
West Jordan 14
Hillsboro 10
Izmir 9
Milan 9
Barcelona 8
Hanover 8
Los Angeles 8
Fiesole 7
Fontebuona 7
Phoenix 7
Andover 6
El Monte 6
Moscow 6
Seoul 6
Auburn Hills 5
London 5
Bari 4
Corigliano Calabro 4
Guangzhou 4
San Giovanni Valdarno 4
Taichung 4
Dearborn 3
Iesi 3
Laurel 3
Ottawa 3
Palermo 3
Perugia 3
Viareggio 3
Washington 3
Bergamo 2
Castelliri 2
Chengdu 2
Chiswick 2
Düsseldorf 2
Farra di Soligo 2
Grevenbroich 2
Hangzhou 2
Hounslow 2
La Ceiba 2
Redwood City 2
Rome 2
Scandicci 2
Seelow 2
Strona 2
Toronto 2
Turin 2
Wakefield 2
Wanchai 2
Aci Catena 1
Acton 1
Americana 1
Anaheim 1
Antony 1
Bologna 1
Busto Arsizio 1
Cairo 1
Campi Bisenzio 1
Cedar Knolls 1
Chicago 1
Corciano 1
Cornaredo 1
Frankfurt Am Main 1
Incisa 1
Islington 1
La Spezia 1
Lausanne 1
Totale 4.887
Nome #
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 243
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 229
Magnetic hyperthermia and oxidative damage to dna of human hepatocarcinoma cells 225
8-Oxo-7,8-dihydro-2'-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study. 215
Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective 210
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC) 148
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 147
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1 129
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 125
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. 112
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 109
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells 105
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 103
Alcohol induced hepatic fibrosis: role of acetaldehyde. 101
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells 100
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model. 97
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. 95
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro 94
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. 93
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 90
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 88
Aldehyde Dehydrogenase-2 (aldh2) Gene Is Differently Expressed In Human Liver Fat-storing Cells (hfsc) and Liver-tissues 87
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 87
In vivo effects of rosiglitazone in a human neuroblastoma xenograft 87
Neuropeptide-leukocyte interactions: examples of pharmacological modulation 86
Genetics, alcohol, and cirrhosis 86
Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development 85
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms 82
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury 81
The potential of antidiabetic thiazolidinediones for anticancer therapy. 77
Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transfroming grwoth factor-B1 76
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 76
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production 74
Intracellular signaling pathways activated by reactive oxygen species regulate proliferation and collagen synthesis of human hepatic stellate cells 74
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 72
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. 72
Evidence for tachykinin NK-2b-like receptors in guinea-pig alveolar macrophages. 69
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 69
Peroxisome proliferator-activated receptor gamma (PPARgamma) transcriptional activity is inhibited by acetaldehyde in human hepatic stellate cells (HSC) 69
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 69
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. 68
PPARgamma activation by antidiabetic thiazolidinediones reduces liver fibrosis and hepatic stellate cells activation in vivo 67
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 66
Apolipoprotein AI regulatory protein 1 (ARP-1) coordinates profibrogenic responses during liver fibrosis 65
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 64
Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration 63
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 63
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells 61
THU-449-Nuclear orphan receptor COUP-TF2 increases the resistence to anoikis and induces amoeboid movment and metastatic potential in hepatocellular carcinoma 60
Enanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins 57
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 54
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 53
Acetaldehyde inhibits peroxisome proliferator-activated receptor gamma (PPARg) transcriptional activity in hepatic stellate cells. A MAPk/pkcdelta-dependent mechanism. 52
The AAA+ ATPase RuvBL1 localizes to mitochondria and supports HCC cell metabolism. 50
Oxydative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism 47
Peroxisome prolferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells 47
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 45
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 42
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 42
Loss of Hepatic RuvBL1 Causes Chronic Liver Damage and Regeneration, Promoting Hepatocellular Carcinoma 41
Paracrine cross-talk between pancreatic cancer cells and periacinar stellate cells enhanced tumor progression 40
Ligation-mediated polymerase chain reaction detection of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-hydroxycytosine at the codon 176 of the p53 gene of hepatitis c-associated hepatocellular carcinoma patients 40
null 39
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1 39
Human hepatic stellate cells express class I alcohol dehydrogenase and adlehyde dehydrogenase but not cytochrome P4502E1 39
The orphan receptor COUP-TF II (Arp-1) is required for stellate cells activation and is involved in mitogenic responses in activated cells. 38
Tachykinins stimulate Lyso-PAF: acetyl-CoA Acetyltransferase activity in Neutrophils 38
Genetic polymorphisms in ethanol metabolizing enzymes do not influence the severity of alcoholic liver disease in Italian patients. 37
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 36
Reactive oxigen species (ROS) modulate mitogenic and motogenic responses in human hepatic stellate cells 35
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 35
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 34
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 33
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN 33
Peroxisome proliferator-activated receptor Gamma (PPAR Gamma) modulates hepatic stellate cells activation. 32
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 31
Helicobacter pylori infection modulates peroxisome proliferator activated receptor gamma (PPARgamma) expression and transcriptional activity. 30
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism 29
Tgf-beta Effects On the Synthesis of Extracellular-matrix Components By Human Fat-storing Cells Are Modulated By Different Matrices 29
Pentoxifylline causes degradation of procollagen I produced by human hepatic stellate cells in response to transforming growth factor-beta 1 27
Oxidative stress induce collagen synthesis by c-Abl activation in human hepatic stellate cells 26
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 26
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 24
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 23
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 20
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 18
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 13
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma 13
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 11
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 7
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 5
Totale 6.323
Categoria #
all - tutte 20.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.278 0 107 34 110 163 170 148 176 138 85 122 25
2020/2021818 74 73 79 81 33 101 31 68 67 106 43 62
2021/2022558 22 49 23 33 25 24 23 29 23 26 127 154
2022/20231.619 125 317 76 139 99 279 205 82 203 6 39 49
2023/2024713 34 66 97 29 64 116 33 129 9 41 44 51
2024/2025208 145 63 0 0 0 0 0 0 0 0 0 0
Totale 6.323